Literature DB >> 2719076

Tumor cell growth fractions in human malignant melanomas and the correlation to histopathologic tumor grading.

P Kaudewitz1, O Braun-Falco, M Ernst, M Landthaler, W Stolz, J Gerdes.   

Abstract

The growth fraction (GF) of 72 human malignant melanomas was determined by immunostaining with monoclonal antibody Ki-67. A positive correlation of GF and histopathologically-assessed prognostic variables, such as tumor thickness, mitotic rate, and prognostic index, was found. Individual Ki-67 values were considerably scattered in all histologically defined groups of malignancy. Thus, GF as determined by Ki-67 was used to calculate a modified prognostic index. In contrast to the histologically defined prognostic index, the Ki-67 based prognostic index allows further subdivision of thin malignant melanomas with no or few mitotic figures. This may be of help in identifying tumors with a high recurrence potential.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2719076      PMCID: PMC1879900     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  16 in total

1.  [Treatment of malignant melanoma (clinical stages I and II) (author's transl)].

Authors:  J Tonak; P Hermanek; O P Hornstein; F Weidner
Journal:  Dtsch Med Wochenschr       Date:  1976-03-19       Impact factor: 0.628

2.  Prognostic index for malignant melanoma.

Authors:  A W Kopf; D F Gross; G S Rogers; D S Rigel; L J Hellman; M Levenstein; B Welkovich; R J Friedman; D F Roses; R S Bart
Journal:  Cancer       Date:  1987-03-15       Impact factor: 6.860

3.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

4.  Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas.

Authors:  J Gerdes; H Stein; S Pileri; M T Rivano; M Gobbi; E Ralfkiaer; K M Nielsen; G Pallesen; H Bartels; G Palestro
Journal:  Lancet       Date:  1987-08-22       Impact factor: 79.321

5.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

6.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

7.  Diagnosis, prognosis, and treatment of melanoma.

Authors:  J D Everall; P M Dowd
Journal:  Lancet       Date:  1977-08-06       Impact factor: 79.321

8.  Comparison of the classification by microscopic level (stage) of malignant melanoma by three independent groups of pathologists.

Authors:  S C Suffin; J Waisman; W H Clark; D L Morton
Journal:  Cancer       Date:  1977-12       Impact factor: 6.860

9.  Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67.

Authors:  T M Grogan; S M Lippman; C M Spier; D J Slymen; J A Rybski; C S Rangel; L C Richter; T P Miller
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

10.  Thin malignant melanomas and recurrence potential.

Authors:  H M Shaw; W H McCarthy; S W McCarthy; G W Milton
Journal:  Arch Surg       Date:  1987-10
View more
  14 in total

1.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Authors:  J Gerdes; L Li; C Schlueter; M Duchrow; C Wohlenberg; C Gerlach; I Stahmer; S Kloth; E Brandt; H D Flad
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

Review 2.  How malignant is malignant? A brief review of the microscopic assessment of human neoplasms, and the prediction of whether they will metastasize and kill.

Authors:  I Carr; N Pettigrew
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

3.  Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.

Authors:  S A Swanson; J J Brooks
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

4.  Proliferative activity of keratinocytes correlates with that of melanocytes in naevi and melanomas.

Authors:  M Tronnier; R Kämmerer; H H Wolff
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

5.  A comparative study of cell proliferation markers in breast carcinomas.

Authors:  A S Leong; S Vinyuvat; C Suthipintawong; J Milios
Journal:  Clin Mol Pathol       Date:  1995-04

6.  The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.

Authors:  R Schröder; K Bien; R Kott; I Meyers; R Vössing
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  A new quantitative test method for cell proliferation based on detection of the Ki-67 protein.

Authors:  C L Klein; M Wagner; C J Kirkpatrick; T G Van Kooten
Journal:  J Mater Sci Mater Med       Date:  2000-02       Impact factor: 3.896

8.  Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1: correlation with peritumoural oedema and other clinicoradiological and histological characteristics.

Authors:  Paulo Henrique Aguiar; Ana Maria Tsanaclis; Oswaldo Inácio Tella; José Pindaro Plese
Journal:  Neurosurg Rev       Date:  2003-04-08       Impact factor: 3.042

9.  Proliferative activity of cutaneous melanocytic neoplasms defined by a proliferating cell nuclear antigen labelling index.

Authors:  Y Tokuda; K Mukai; Y Matsuno; S Furuya; Y Shimosato; Y Takasaki; T Saida; K Ishihara
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

10.  Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.

Authors:  A E Dawson; J A Norton; D S Weinberg
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.